SCHEMBL23867476

SCHEMBL23867476

O=C(Nc1ccc(Nc2ccnc(N3CCCC3)n2)cc1)c1c[nH]c2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.55
▸ MAPK8 P45983 1/20 0.50
▸ CDC7 O00311 1/20 0.50
▸ PTPN11 Q06124 1/20 0.47
▸ CCNE1 P24864 3/20 0.47
▸ CDK2 P24941 3/20 0.47
▸ HTR2C P28335 7/20 0.46
▸ CFTR P13569 2/20 0.44
▸ ROCK2 O75116 2/20 0.43
▸ PTGDR2 Q9Y5Y4 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ HSP90AB1 P08238 1/20 0.43
▸ GABRA1 P14867 1/20 0.42
▸ GABRB1 P18505 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ GABRA3 P34903 1/20 0.42
▸ GABRA2 P47869 1/20 0.42
▸ GABRB2 P47870 1/20 0.42
▸ GABRA4 P48169 1/20 0.42
▸ GABRA6 Q16445 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867512 0.89 ACHE (0.50) HRH3PTPN11CCNE1CDK2HTR2C
SCHEMBL23859943 0.85 HRH3 (0.53) HRH3CCNE1CDK2HTR2CCFTR
SCHEMBL30165658 0.85 HRH3 (0.53) HRH3CCNE1CDK2HTR2CCFTR
SCHEMBL23867510 0.82 HRH3 (0.52) HRH3PTPN11HTR2CROCK2
SCHEMBL23867481 0.81 HRH3 (0.51) HRH3PTPN11HTR2CCFTRGABRA1
SCHEMBL23867482 0.78 HRH3 (0.52) HRH3HTR2CCFTRPTGDR2
SCHEMBL23867513 0.77 MAPK8 (0.44) MAPK8CDC7CDK2ROCK2HSP90AA1
SCHEMBL23867572 0.76 ACHE (0.48) CCNE1CDK2
SCHEMBL30234371 0.76 ROCK1 (0.46) CCNE1CDK2ROCK2
SCHEMBL23867521 0.75 HTR1A (0.50) HRH3CCNE1CDK2HTR2CPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback